Direct targeting of NUP210 protein has not been demonstrated, however targeting of the transcriptional and epigenetic regulator, Bromodomian-containing protein 4 (BRD4) with an aminocyclopropenone (ACP) has been explored, ACP-1n has demonstrated inhibition of NUP210 expression in colorectal cancer cells. This evidence concerns the gene NUP210 and colorectal cancer.